Windlas Biotech Buyback Record Date is 24 April 2026.
Windlas Biotech is a premier Indian pharmaceutical company and a top-tier Contract Development and Manufacturing Organisation (CDMO) founded in 2001. Headquartered in Dehradun, the company provides end-to-end manufacturing solutions for a wide variety of pharmaceutical products. Their expertise spans complex dosage forms, including diverse tablet technologies—such as enteric-coated, sustained-release, and bilayer—capsules featuring pellet and powder combinations, and specialised liquid emulsions. Recently, the company significantly expanded its capabilities by launching a modern injectables facility designed to deliver advanced sterile solutions for both the Indian and global export markets.
The company has an annual production capacity exceeding 7 billion units for tablets and capsules. It is recognised for quality standards, holding prestigious clearances from the USFDA, WHO GMP, and ISO. Apart from manufacturing, Windlas is also present in the trade, generics, and Institutional sectors.
Windlas Biotech Buyback Record Date, Other Details
| Windlas Biotech Buyback Dates | Coming soon |
| Windlas Biotech Buyback Price | INR 1,000 per share |
| Market Price on Buyback Approval | INR 865.40 per share |
| Buyback Premium on Market Price | 15.55% |
| Buyback Offer Size (Shares) | 4,70,000 shares |
| Buyback Offer Size (Amount) | INR 47 crore |
| Offer Type | Tender |
| Promoter Participation | Nil |
| Face Value | INR 5 per share |
| Listing At | BSE, NSE |
Windlas Biotech Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 15 April 2026 |
| Buyback Approval Date | 17 April 2026 |
| Public Announcement of Buyback | Coming soon |
| Windlas Biotech Buyback Record Date | 24 April 2026 |
| Buyback Opening Date | Coming soon |
| Buyback Closing Date | Coming soon |
| Cut-off Date to receive completed tender forms by Registrar | Coming soon |
| Verification Date by the Registrar | Coming soon |
| Return of unaccepted shares by Registrar | Coming soon |
| Extinguishment of accepted shares | Coming soon |
Windlas Biotech Buyback 2026 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Windlas Biotech Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | – | 2.39* |
| General category (for all other Eligible Shareholders) | – | – |
A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Windlas Biotech Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Total Income | 513 | 631 | 760 |
| Total Expenses | 453 | 553 | 666 |
| Net Income | 43 | 58 | 61 |
Calculation of Investment in Buyback
| Maximum market value of a shareholder as on record date | INR 2,00,000 |
| Buyback price per share | INR 1,000 |
| Maximum shares for small shareholders (2,00,000/1,000) | 200 shares * |
| The closing price of the stock as of 17 April 2026 | INR 865.40** |
| Maximum amount invested in buyback (INR 865.40 x 200 shares) | INR 1,73,080 |
** For simplicity, we have considered the price on the buyback approval date
Windlas Biotech Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 200 | 5 | 5 (100%) | 673 | 0.39 |
| 200 | 5 | 10 (200%) | 1,346 | 0.78 |
| 200 | 5 | 15 (300%) | 2,019 | 1.17 |
Registrar of Windlas Biotech Buyback 2026
Coming soon
Manager of Windlas Biotech Buyback 2026
Coming soon
The Process to Participate in Windlas Biotech Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Windlas Biotech buyback dates?
Windlas Biotech’s buyback opens on May 2026 and closes on May 2026.
Which type of buyback is Windlas Biotech‘s buyback offer?
Windlas Biotech’s buyback is a tender offer.
What is Windlas Biotech buyback price?
Windlas Biotech’s buyback price is INR 1,000 per share.
What is the Windlas Biotech buyback record date?
Windlas Biotech buyback record date is 24 April.
How to participate in Windlas Biotech share buyback?
Windlas Biotech share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.
